Novo CEO pressed by Senate to chop price ranges of weight problems, diabetic issues medicines CEO Lars Fruergaard Jørgensen informed lawmakers the company would look at new talks with insurers regarding the listing price ranges of Wegovy and copyright should they pledge to keep the medicines on their own formularies. https://kethek.com/